Xianliang Lai
Nanchang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Combined ipsilateral peak systolic velocity and ASPECTS are associated with early neurological deterioration after endovascular thrombectomy: a prospective cohort study.
Journal: BMC neurology
Published: December 30, 2025
Comparison of LVIS and Enterprise stent-assisted coiling embolization for ruptured intracranial aneurysms: a propensity score-matched cohort study.
Journal: Neurosurgical review
Published: January 17, 2024
Mechanism of ischemic brain injury repair by endothelial progenitor cell‑derived exosomes.
Journal: Molecular medicine reports
Published: August 15, 2020
Regulatory mechanism of MiR-21 in formation and rupture of intracranial aneurysm through JNK signaling pathway-mediated inflammatory response.
Journal: International journal of clinical and experimental pathology
Published: March 14, 2019
Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy.
Journal: International journal of nanomedicine
Published: June 05, 2018
HP1α is highly expressed in glioma cells and facilitates cell proliferation and survival.
Journal: Cancer biomarkers : section A of Disease markers
Published: September 27, 2017
HP1α is highly expressed in glioma cells and facilitates cell proliferation and survival.
Journal: Biochemical and biophysical research communications
Published: May 29, 2017
Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Journal: Drug delivery
Published: May 17, 2016
Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy.
Journal: Drug delivery
Published: May 29, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026